From feelings charts to continuous vitals
OpiAid’s watch does not measure anxiety or depression directly; instead, its sensors pick up changes in HRV and activity that can correlate with stress, cravings or impending withdrawal. When those metrics cross preset thresholds, a HIPAA-compliant platform alerts care teams so they can check in with the patient before a crisis escalates. The company says raw data are encrypted in transit and at rest, and dashboards require multi-factor authentication. The device is not yet cleared under an FDA 510(k); OpiAid is supplying it under enforcement discretion while it collects outcome data.
“It’s the difference between a flip phone and an iPhone,” OpiAid spokesperson Dino Miliotis told The Business Journal. “We’ve been using the same system for forty years. This changes everything about recovery.” For now, the change is limited: the Fresno rollout covers roughly two dozen patients, with four additional state-funded pilots slated in North Carolina, South Carolina, Alaska and Oklahoma. Insurance coverage is still “to be determined,” because Medicare’s RPM codes generally require FDA-listed hardware.
Part of a wider remote-patient-monitoring wave
The launch echoes momentum elsewhere in digital health. In April 2025 Amazon Web Services and biosensor vendor Vivalink released a generic cloud stack for remote patient monitoring, signaling big-tech interest in streaming vitals beyond the hospital. Regulators are watching closely: draft updates to CMS billing rules would standardize how behavioral-health clinics claim reimbursement for continuous physiologic data, while privacy advocates stress the need for clear consent and secure storage.
The Fresno team hopes that early intervention—triggered by biometric anomalies rather than missed counseling sessions—will improve retention and long-term sobriety. Founder Flindt Anderson, who also runs the PAIN (Patients and Addicts In Need) nonprofit and hosts the “Don’t Hide the Scars” podcast, says the objective data already help staff triage limited counseling resources. Whether the technology scales will depend on peer-reviewed outcomes, payer acceptance and federal clearance, but the pilot underscores a growing belief that real-time physiology could give addiction care a much-needed update.
Source: The Business Journal
—
By Ali Nassar-Smith
